Background-New therapeutic approaches to improve cardiac contractility without severe risk would improve the management of acute heart failure. Increasing systolic sodium influx can increase cardiac contractility, but most sodium channel activators have proarrhythmic effects that limit their clinical use. Here, we report the cardiac effects of a novel positive inotropic peptide isolated from the toxin of the Black Judean scorpion that activates neuronal tetrodotoxinsensitive sodium channels. Methods and Results-All venoms and peptides were isolated from Black Judean Scorpions (Buthotus Hottentotta) caught in the Judean Desert. The full scorpion venom increased left ventricular function in sedated mice in vivo, prolonged ventricular repolarization, and provoked ventricular arrhythmias. An inotropic peptide (BjIP) isolated from the full venom by chromatography increased cardiac contractility but did neither provoke ventricular arrhythmias nor prolong cardiac repolarization. BjIP increased intracellular calcium in ventricular cardiomyocytes and prolonged inactivation of the cardiac sodium current. Low concentrations of tetrodotoxin (200 nmol/L) abolished the effect of BjIP on calcium transients and sodium current. BjIP did not alter the function of Nav 1.5 , but selectively activated the brain-type sodium channels Nav 1.6 or Nav 1.3 in cellular electrophysiological recordings obtained from rodent thalamic slices. Nav 1.3 (SCN3A) mRNA was detected in human and mouse heart tissue. Conclusions-Our pilot experiments suggest that selective activation of tetrodotoxin-sensitive neuronal sodium channels can safely increase cardiac contractility. As such, the peptide described here may become a lead compound for a new class of positive inotropic agents. (Circ Heart Fail. 2015;8:79-88.
H eart failure kills in equal proportions either by a critical loss of contractile cardiac function or by sudden caused by ventricular arrhythmias. [1] [2] [3] Currently available inotropic agents (sympathomimetic agents, calcium sensitizers, or phosphodiesterase inhibitors) improve hemodynamic function at the price of potentially fatal proarrhythmic side effects and the deleterious consequences of chronic β-adrenoreceptor stimulation. Hence, inotropic therapy is confined to patients with severe, acutely decompensated heart failure treated on intensive care units. 1, 2 An inotropic therapy without these side effects would clearly be desirable in the management of acute heart failure. January 2015 Cardiac contraction is initiated by calcium release from the sarcoplasmic reticulum in cardiomyocytes. The trigger for calcium influx into the cell is an influx of sodium into the cardiomyocyte initiated through opening of voltagegated sodium channels. Thereafter, opening of voltage-gated calcium channels, exchange of sodium and calcium via the sodium-calcium exchanger, and calcium-activated calcium release from the sarcoplasmic reticulum accentuate this initial stimulus. Voltage-gated sodium channels, an evolutionary well-preserved group of sarcolemmal transmembrane proteins, regulate voltage-dependent sodium influx and electric excitability in neuronal and cardiac tissue. 4 Activators of cardiac sodium channels are known to not only exert positive inotropic effects but also cause arrhythmias. 5 Cardiac sodium channels can be divided into tetrodotoxin-resistant (µmol/L range) and tetrodotoxin-sensitive (nmol/L range) channel subtypes. 4 The main isoform of the tetrodotoxin-resistant sodium channels Nav 1.5 is expressed predominantly in cardiomyocytes. 4 Selective increase in the opening kinetics of Nav 1.5 causes atrial fibrillation and heart failure, 6, 7 and genetic variants in the Nav 1.5 channel are associated with defibrillator shocks in patients with heart failure. 8 This may explain why activators of Nav 1.5 are not used in patients with heart failure, despite their positive inotropic effects. 9 Tetrodotoxin-sensitive sodium channels, in contrast, are mainly expressed not only in mammalian brain and in skeletal muscle 4, 10 but also in T tubules of cardiomyocytes close to calcium-releasing organelles. 10, 11 Selective activation of tetrodotoxin-sensitive sodium channels could hence provide a leverage to improve cardiac contraction without interfering with the electrophysiological function of cardiomyocytes. This has, however, never been formally tested. Here, we report about a peptide isolated from the venom of the Black Judean Scorpion, BjIP, which confers positive inotropy without proarrhythmic effects. This beneficial combination of effects seems to be mediated by selective activation of neuronal tetrodotoxin-sensitive sodium channels (most likely Nav 1.3 and Nav 1.6 ).
Methods
All Methods are available in the in the Data Supplement.
Venom Harvesting and Isolation of the Inotropic Peptide BjIP
The full venom was harvested from Hottentotta judaicus scorpions. All venom and peptide fractions were harvested and prepared in Israel, and shipped to Muenster for functional and molecular analyses.
Molecular Characterization of BjIP
The inotropic peptide was characterized by Matrix-Assisted Laser-Desorption Ionization-Time-Of-Flight Mass Spectrometry. The N-terminal amino acid sequence (33 amino acids) was determined using Edman degradation. Total RNA isolated from the Black scorpion venom gland was used for cDNA synthesis by the aid of SMART approach (Clontech, Park Tamar, Israel).
Real-Time Quantitative Polymerase Chain Reaction of Na + Channels in Heart Tissue
Total RNA was prepared from freshly dissected tissue by extraction with Trizol reagent (RNeasy Lipid Tissue; Qiagen, Düsseldorf, Germany). Further details are available in the Data Supplement.
Dose Selection for the Full Venom and the Inotropic Peptide
The limited access to BjIP required careful dose selection throughout the project. Preliminary experiments showed a positive inotropic effect of the full venom at 4 µg/mL. Considering the expected weight contribution of BjIP to the protein content of the full venom (10%), we chose the concentrations given below for the initial functional assessment of the full venom and of BjIP (Table) . After the trabecular experiments demonstrating a positive inotropic effect of the BjIP at 1/10 of the initial concentration of BjIP, we reduced the concentration of BjIP for further cellular mechanistic experiments.
Murine Echocardiography
Cardiac function was measured during anesthesia on HP5500 and Vevo770 ultrasound microscopy systems (Visualsonics, Canada; 50-70 MHz transducers) in adult 3 months old CD1 wild-type mice. 12 In brief, sedated animals were studied while spontaneously breathing. After establishing a stable physiological situation, left ventricular function was assessed in real-time by M mode echocardiography at baseline and after intraperitoneal injection of the full venom (40 µg) or the inotropic peptide (BjIP; 2 µg). Cardiac contraction was monitored for 20 minutes after injection.
Electrophysiological Measurements in the Isolated Heart
Hearts of 3-month-old wild-type mice were isolated and retrogradely perfused (oxygenated modified Krebs-Henseleit solution, 37°C temperature, pH 7.4) on a modified Langendorff apparatus. Monophasic action potentials were recorded from the right and left ventricles of beating hearts. 12, 13 The atrioventricular node was ablated to generate ventricular bradycardia. After a stabilization period of 10 minutes, spontaneous rhythm was observed, and ventricular pacing was performed at fix rates to assess ventricular action potential durations. The protocol was repeated after adding BjV or BjIP to the perfusate (Table) .
Recording of Sodium Current (I Na ) in Murine Cardiomyocytes
Ventricular cardiomyocytes were isolated and prepared for patch clamp experiments as described. 14 Cells were exposed to BjIP (4 µg/ mL) and tetrodotoxin (200 nmol/L) by a gravity-driven fast application system (Warner, Holliston, MA). The inactivation time constant τ was derived from single exponential fits to the I Na decay phase (Fitmaster, HEKA, Lambrecht, Germany). The total sodium influx was estimated by I Na integration as the area under curve.
Cardiomyocytes Shortening and Calcium Transient Measurements
Cell shortening was measured in electrically driven (0.5 Hz) mouse ventricular cardiomyocytes. Cells were isolated and mounted in tissue chambers, containing a modified Tyrode solution, for recording of cell shortening. 15 After a pre-equilibration period of 30 minutes, BjIP solution (0.4 µg/mL) was superfused to the cardiomyocytes for 5 minutes. As a control, 200 nmol/L tetrodotoxin was applied, followed by BjIP. Cell shortening, time to peak tension, and relaxation time (90%) were continuously monitored during the measurement. For calcium transient measurements, indo-1 fluorescence ratio (Ca2+) and cell shortening (Crescent Electronic Video Edge Motion Detector) were recorded simultaneously from isolated murine cardiomyocytes at room temperature during field stimulation at 0.5 Hz. 16
Single-Cell Electrophysiology in Acute Living Brain Slices
Brains were removed from decapitated rats and placed in an icecold, oxygenated solution. Acute living brain slices (280-µm thickness) containing the dorsal part of the lateral geniculate nucleus of the thalamus (dLGN) were cut on a vibratome (Leica VT1200, Wetzlar, Germany) and kept submerged in solution, and recording pipettes were inserted into neuronal cells. Slices were continuously superfused with a bath solution. After establishment of the whole cell configuration, cells were superfused with a low Na + -solution. Signals were amplified (EPC-10, HEKA) and digitally analyzed using Pulse software. µ-Conotoxin PIIIA (µCtx; Alomone, Jerusalem, Israel), Pro-TX-II (Pro-TX; Alomone), which selectively inhibit distinct isoforms of voltage-dependent Na + channels, or tetrodotoxin (Tocris, Bristol, United Kingdom), were added directly into the bath. Recordings were obtained at baseline and during BjIP superfusion in identical cells.
All functional experiments were approved by the Bezirksregierung in Münster, Germany, and conformed to the local and international regulation for experiments in animals.
Statistical Analysis
We compared categorical data using Fishers exact test. Numeric data were compared by 2-sided paired t tests (eg, measurements before and after perfusion of BjIP or BJCV), Wilcoxon signed-rank tests. For multiple measurements, data were analyzed by repeated measures ANOVA followed by a multiple comparison procedure (Bonferroni t test) if the overall test was significant. For thalamic recordings, a 1-sided (expected increase for BjIP; expected decrease for commercial blockers) test was used. Data were considered significantly different at P values <0.05. When data are displayed as boxplots, boxes and box limits indicate the data range mean, and SE. Whiskers indicate the minimum and maximum of the respective data. Individual measurements are shown in the boxplots as points.
Results

BjIP Has Inotropic Effects Without Prolonging Cardiac Repolarization or Provoking Arrhythmias
The complete venom of Hottentotta judaicus (BjV), when injected intraperitoneally into anesthetized albino CD1 mice (0.7-1.0 mg/mouse; n=5) did neither kill nor affect locomotion. BjV (0.2 mg/mouse IP) increased ventricular contractility by 20% to 25% and caused ventricular arrhythmias ( Figure 1A and 1B). When perfused in isolated, beating mouse hearts, BjV provoked ventricular arrhythmias and prolonged the ventricular action potential ( Figure 1C-1F ). Reversed-phase high-performance liquid chromatography identified an inotropic peptide. Intraperitoneal application of 20-µg BjIP increased contraction of the murine heart in vivo to a similar extent as the full venom ( Figure 1A and 1B) . In contrast to the full venom, BjIP did neither provoke ventricular arrhythmias when administered intraperitoneally in vivo ( Figure 1A ) nor during perfusion in the isolated heart ( Figure 1C and 1D ). Furthermore, BjIP did not prolong action potential duration in the isolated, beating heart (4 µg/mL BjIP; Figure 1E -1G).
Primary Sequence and Predicted Tertiary Structure of BjIP Closely Resemble Scorpion Venom Long-Chain Neurotoxins Affecting the Voltage-Gated Sodium Channels
BjIP was sequenced, and its tertiary structure was modeled ( 
Positive Inotropic Effects of BjIP Are Tetrodotoxin Sensitive
BjIP superfusion enhanced contractility in right ventricular mouse trabecles ( Figure 3A ) and increased contractility and intracellular calcium transients in paced mouse ventricular cardiomyocytes ( Figure 3B-3E ). Furthermore, BjIP delayed inactivation of the cardiac sodium current without affecting peak current amplitude ( Figure 3F-3I ). Nanomolar concentrations of tetrodotoxin antagonized the effect of BjIP on contractility ( Figure 3A ), calcium transients ( Figure 3D and 3E) , and I Na (Figure 3F-3I ).
BjIP Activates Neuronal Sodium Channels
Fast inward currents in thalamocortical neurons 17 indicated a sufficient voltage control and space clamp to assess Na currents ( Figure 4A ). Current amplitudes increased by application of BjIP (0.44 µg/mL; +16.1±8.4%; n=7; Figure 4A and 4C). The inactivation time constant of I Na was best fitted by a single exponential function at room temperature ( Figure 4B , 4E, and 4G, τ=4.9±0.8 ms for the step to −30 mV; n=7). No changes in current decay were detected in the presence of BjIP τ=5.0±0.5 ms (n=7; Figure 4B ). µCtx 18 reduced I Na by −19.4±3.9% (n=4; Figure 4F ). In the presence of µCtx, BjIP increased I Na amplitudes by 13.2±6.0% compared with control (n=4; Figure 4F ). Pro-Tx (0.5 µmol/L 19 ) reduced I Na amplitudes by −27.5±6.6% (n=5; Figure 4D and 4G). In the presence of Pro-Tx, BjIP had no effect on current amplitudes (n=5; Figure 4D and 4G). Additional application of tetrodotoxin (1 µmol/L) nearly inhibited I Na in thalamocortical neurons completely ( Figure 4D ). 
Expression of Tetrodotoxin-Sensitive Na Channel Genes in Murine Brain and Heart and in Human Heart Tissue
From the 10 known Na V 1 channel genes, mRNA of SCN1A (Na V 1.1), SCN2A (Na V 1.2), SCN3A (Na V 1.3), SCN8A (Na V 1.6), SCN11A (Na V 1.9), and SCN7A (Na X ) was detected in thalamic tissue ( Figure 4H ). mRNA of the other Na + channels was below detection limit in thalamus. Quantitative polymerase chain reaction was used for heart tissue. Relevant expression of SCN3A mRNA, but not of SCN8A mRNA, was detected in human and murine ventricular tissue, and slightly higher SCN3A mRNA levels were found in specialized conduction tissue (Purkinje fibers and AV node; Figure 5 ). These findings together with the subtype specificity of µCtx and Pro-Tx make Na V 1.3 channels the most likely candidates for positive modulation by BjIP.
Discussion
Main Findings
Within the limitations of studying a biological toxin that had to be harvested and purified for each experiment, our findings suggest that selective activation of neuronal, tetrodotoxinsensitive sodium channels in the heart (most likely Nav 1.3 channels) by a peptide isolated from the venom of Buthotus Hottentotta may be a novel therapeutic principle to increase cardiac contractility without proarrhythmic side effects. Additional experiments are needed to validate our encouraging preliminary findings. Currently available positive inotropic agents modulate not only unspecific kinases in cardiomyocytes, such as protein kinase C, but also calcineurin or calcium-dependent calmodulin kinase II. 20, 21 These kinases not only increase cAMP levels in the myocardium and thereby increase calcium release from the sarcoplasmic reticulum but also alter the function of the main cardiac sodium channel Nav 1.5 by phosphorylation, 21 and thereby increase cardiac contractility. Activators of the main cardiac sodium channel Nav 1.5 increase contractility. 5, 22 Activation of Nav 1.5 , however, also prolongs repolarization 5, 22 and provokes ventricular arrhythmias. 23 Tetrodotoxin-sensitive sodium channels contribute to sodium influx and increased contractility in the heart: Approximately 25% of mammalian cardiac sodium channels are tetrodotoxin sensitive, and preferentially localized close to the T tubules. 11 Our own quantitative polymerase chain reaction measurements confirm that SCN3A/Nav1.3 mRNA is present in human and mouse ventricular tissue ( Figure 5 ), whereas SCN8a/Nav1.6 mRNA is not found in the heart, consistent with a recent report in rats ( Figure 5 24 ). Insect toxins can have inotropic effects in large mammals, 25 and nanomolar concentrations of tetrodotoxin exert a negative inotropic effect (−20%) in beating guinea-pig hearts. 10 It is noteworthy that a similar phenomenon, although less noticeable, can be seen in Figure 3D and 3E, where tetrodotoxin (200 nmol/L) reduces contractility slightly below control values.
Similar to the Nav 1.5 activators and to apelin, 26 the full venom of the Hottentotta judaicus not only has inotropic effects but also prolongs the ventricular action potential and provokes ventricular arrhythmias (Figure 1 ). BjIP, in contrast, increased contractility in vivo and in cardiomyocytes without proarrhythmic effects (Figure 1 ). Furthermore, the effect of BjIP was reversed by tetrodotoxin ( Figure 3 ), suggesting an action on tetrodotoxin-sensitive cardiac sodium channels, ie, Nav 1.1 , Nav 1.2 , Nav 1.3 , Nav 1.4 , Nav 1.6 or Nav 1.7 , 4,27 or alternatively spliced Nav 1.5 sodium channels. 28 Although we could not measure full I-V relationships because of limited amounts of BjIP, we have sufficient data to show that BjIP delays I Na inactivation without altering I Na amplitude. Our electrophysiological experiments in thalamic slices suggest that BjIP activates Nav 1.3 and Nav 1.6 (Figure 4 ). Consistent with published reports, 4, 11, 27, [29] [30] [31] we find the expression of Nav 1.3 channel mRNA in ventricular myocardium. Thus, it seems likely that the inotropic effect of BjIP is mediated by the activation of Nav 1.3 , possibly initiating a localized increase in sodium close in the T tubules of cardiomyocytes 11 close to the sarcoplasmic reticulum, where even a small sodium influx can increase local calcium concentrations and facilitate calcium release from the sarcoplasmic reticulum. 32 A similar alteration in local calcium homeostasis was proposed in multiple sclerosis where axonal injury is caused by increased Nav 1.6 channels in demyelinated axons and alters sodium-calcium exchange. 33 Alternatively, sodium influx close to the T tubules may synchronize excitation-contraction coupling, and thereby improve inotropy. 10, 11 BjIP may also increase diastolic sodium load in the cell by providing additional substrate to the sodium-calcium exchanger through activation of Nav 1.3 channels, as has been shown for the Nav 1.5 opener veratridine. 34 These possibilities deserve further experimental examination. Of note, Nav 1.6 , but not Nav 1.3 mRNA expression is increased in response to pressure overload, rendering activation of Nav 1.6 channels relevant in hypertrophied and failing hearts. 30 Thus, the activation of Nav 1.3 and Nav 1.6 seems a promising new cardiac inotropic principle.
Limitations
We performed the experiments for a period of several years using different preparations of the peptide, limited by the available amount of the purified peptide obtained from freely living scorpions collected in the Negev Desert. Our attempts to generate recombinant BjIP have to date not allowed us to obtain an adequately folded peptide in sufficient amounts. 35 Clearly, recombinant BjIP would be desirable to perform experiments in large animal models and in failing hearts, and to provide unambiguous evidence that the observed effects were mediated by BjIP and not by contaminations. These limitations notwithstanding, our data suggest that selective activation of the neuronal, tetrodotoxin-sensitive sodium channels, most likely including Nav 1.3 , is a promising target for the development of novel inotropic substances.
Further Research Directions
Our observations invite further studies, eg, examining the following issues: (1) Providing dose-response curves for the effect of BjIP on different Na channels; (2) determining whether Nav Pro-Tx is an inhibitor of Na V 1.2, Na V 1.3, Na V 1.5, Na V 1.6, Na V 1.7, and Na V 1.8. H, mRNA expression of SCN1A (Na V 1.1), SCN2A (Na V 1.2), SCN3A (Na V 1.3), SCN4A (Na V 1.4), SCN5A (Na V 1.5), SCN8A (Na V 1.6), SCN9A (Na V 1.7), SCN10A (Na V 1.8), SCN11A (Na V 1.9), and SCN7A (Nax) in thalamic brain tissue. DNA marker bands are located in the left margin. X indicates channels that are inhibited by µCtx or Pro-Tx.
hearts, where Na channel expression, calcium handling, metabolic state, and Na channel function may be altered; (4) determining the effect of BjIP in ischemia-reperfusion models; (5) assessing whether BjIP may have a specific antiarrhythmic effect that could explain that cardiac action potential duration and ventricular arrhythmias are not affected by BjIP. showing detection of SCN3A and SCN5A mRNA in human heart and blood and in mouse heart tissue. SCN8A mRNA is not detectable in the heart, but it is readily detected in human leucocytes. B, Mean expression levels of SCN3A (black), SCN5A (gray), and SCN8A (nondetectable) mRNA in mouse ventricular tissue derived from quantitative PCR (qPCR). C, Mean expression levels derived from qPCR of SCN3A (black), SCN5A (gray, reference, set to 1), and SCN8A (not detected) mRNA in human heart tissue taken from different regions (ie, atria, ventricles, sinus node, AV node, and Purkinje fibers). ΔCt-means were used to express mRNA expression normalized to SCN5A expression applying 2-ΔΔCt-method.
